Dr. Myers said: "I am pleased to be taking on this new position within Mylan. Dey's industry-leading respiratory business will form the base of a strong specialty division, which is highly complimentary to the new Mylan. I look forward to working with Christy and the other members of Dey's senior management team to take this already strong business to a new level."
Mr. Coury continued: "Christy is an outstanding individual and leader, who has played a pivotal part in the development of Dey's business. Combining Carolyn's background with Christy's general management expertise and intimate knowledge of Dey will ensure that Mylan effectively and efficiently capitalizes on the business opportunities in the global specialty pharmaceutical industry."
Ms. Taylor commented: "I am excited to be taking on this new expanded role within Dey. Over the past few months, I have had the privilege to get to know Carolyn and other members of the Mylan senior management team and am excited by the fact that we share a similar culture, values, and a commitment to creating a strong specialty business. "
As part of the management integration, Mel Engle, Dey's current President and Chief Executive Officer, will step down. Mr. Engle will remain President of Dey until December 31, 2007 at which point he will be formally succeeded by Dr. Myers. Ms. Taylor's new position as Chief Operating Officer of Dey will take effect immediately. During the transition, Dr. Myers will also continue to oversee Mylan Technologies.
Dr. Myers received her Ph.D. from the University of British Columbia, Canada, a post-doctorate degree from the University of Wisconsin and a Master's in Business Administration from Rutgers University.
Ms. Taylor earned her Bachelor of Science in Business from St. Mary's College, and her Master's in International Business from the American Graduate School of International Management.
Mylan Inc. is one of the world's le
|SOURCE Mylan Inc.|
Copyright©2007 PR Newswire.
All rights reserved